|
CD9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.2131999999917E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.34489999999932E-05 |
| Normal-vs-Stage2 |
2.621900E-02 |
| Normal-vs-Stage3 |
7.49422746082473E-12 |
| Normal-vs-Stage4 |
8.02946598099652E-12 |
| Stage1-vs-Stage2 |
7.345400E-01 |
| Stage1-vs-Stage3 |
7.835600E-04 |
| Stage1-vs-Stage4 |
1.121660E-03 |
| Stage2-vs-Stage3 |
5.151500E-02 |
| Stage2-vs-Stage4 |
4.944200E-02 |
| Stage3-vs-Stage4 |
8.666800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26689999602192E-08 |
| Normal-vs-AfricanAmerican |
9.080400E-02 |
| Normal-vs-Asian |
3.737800E-02 |
| Caucasian-vs-AfricanAmerican |
1.786600E-01 |
| Caucasian-vs-Asian |
8.852600E-01 |
| AfricanAmerican-vs-Asian |
3.185000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.54840000055457E-07 |
| Normal-vs-Female |
1.47990000254339E-08 |
| Male-vs-Female |
2.838000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.120500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.41759998079283E-09 |
| Normal-vs-Age(61-80Yrs) |
1.30389999997149E-06 |
| Normal-vs-Age(81-100Yrs) |
1.570730E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.927600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.929000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.519600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.359600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.834400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.806000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.76330000000369E-05 |
| Normal-vs-Grade 2 |
2.798900E-04 |
| Normal-vs-Grade 3 |
2.19030349413174E-11 |
| Normal-vs-Grade 4 |
3.73034936274053E-13 |
| Grade 1-vs-Grade 2 |
1.877810E-01 |
| Grade 1-vs-Grade 3 |
3.071000E-01 |
| Grade 1-vs-Grade 4 |
5.807700E-02 |
| Grade 2-vs-Grade 3 |
2.237700E-03 |
| Grade 2-vs-Grade 4 |
7.59380000000531E-05 |
| Grade 3-vs-Grade 4 |
1.692350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.25270024856172E-10 |
| Normal-vs-ccB subtype |
1.546170E-02 |
| ccA subtype-vs-ccB subtype |
2.208100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49930000004073E-06 |
| Normal-vs-N1 |
4.57549997889828E-09 |
| N0-vs-N1 |
4.800000E-02 |
|
|
